Skip to Navigation | Skip to Content
Post

Novavax Says Its COVID-19 Vaccine Is 89% Effective, Less So Against South African Variant
Huff Post

A coronavirus vaccine developed by Novavax is more than 89% effective in preventing COVID-19, the company announced Thursday, although it is not as useful in preventing infections of a fast-spreading variant of the virus that first emerged in South Africa.